Stevenage, United Kingdom

Andrew David Searle

This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Biota Scientific Management Pty Ltd, Glaxo Group Limited, Smithkline Beecham Corporation. Active years: 1991-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew David Searle. Retrieved from https://idiyas.com/inventor/andrew-david-searle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 50(Granted Patents)


Location History:

  • Acton, GB (1991)
  • Stevenage, GB (1997 - 2003)

Company Filing History:


Years Active: 1991-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Andrew David Searle

Introduction

Andrew David Searle is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating diseases caused by retroviruses. With a total of three patents to his name, Searle's work exemplifies innovation in medicinal chemistry.

Latest Patents

Searle's latest patents include a process for preparing Fostemsavir, which outlines a method for synthesizing a compound of Formula IV. This process involves the preparation of a compound of Formula I, where P is either hydrogen or a suitable protecting group, and R is hydrogen or an alkyl group. Another significant patent is for calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[(4-aminophenyl)sulfonyl](isobutyl)amino-1-benzyl-2-(phosphonooxy)propylcarbamate. This invention relates to the compound's preparation processes and its application in treating retroviral diseases.

Career Highlights

Throughout his career, Searle has worked with prominent companies in the pharmaceutical industry. He has been associated with SmithKline Beecham Corporation and Biota Scientific Management Pty Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Searle has collaborated with notable professionals in his field, including Ian Gordon Armitage and Hardev Singh. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Andrew David Searle's contributions to pharmaceutical inventions demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of chemistry and a dedication to improving treatments for serious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…